Novel Therapeutics in Ovarian Cancer: What to Watch

Novel therapies and combinations in ovarian cancerПодробнее

Treatment ovarian cancer with novel targeted therapies and IOПодробнее

Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-FarberПодробнее

New 2022: Cancer As A Metabolic Disease. Implications For Novel Therapeutics - Thomas Seyfried, PhDПодробнее

Novel Therapeutics – Ovarian Cancer Research Seminar SeriesПодробнее

Novel Therapeutics - Ovarian Cancer Research Seminar SeriesПодробнее

Ovarian Cancer Canada’s OvCAN initiative: Advancing scientific discoveriesПодробнее

Enhancing Personalized Medicine in Ovarian Cancer: Advances in PARP Inhibition and Novel ModalitiesПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Novel Therapies for Newly Diagnosed Advanced Ovarian CancerПодробнее

Identifying novel therapeutic targets to treat dormant ovarian cancer spheroids - CTCR 2018Подробнее

Future Directions in Advanced Ovarian Cancer ManagementПодробнее

The development of novel therapeutics to target endometrial and ovarian tumours - Dr Seydou YaoПодробнее

Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, TargetsПодробнее

Mark Exley: Phosphopeptide NeoAntigens for Tumor Immunity: Novel therapeutic optionsПодробнее

Clostridium Perfringens Enterotoxin (CPE): A Potential Novel Therapy for Ovarian CancerПодробнее

Dr. Sabbatini on Novel Approaches With IP Therapy For Ovarian CancerПодробнее

Using Novel Therapies in Advanced Ovarian CancerПодробнее